中国实用外科杂志 ›› 2022, Vol. 42 ›› Issue (11): 1312-1315.DOI: DOI:10.19538/j.cjps.issn1005-2208.2022.11.23

• 文献综述 • 上一篇    下一篇

胰腺癌肿瘤标记物研究和应用进展

冯佳毅,赵宇豪,王许安,刘颖斌   

  1. 上海交通大学医学院附属仁济医院胆胰外科  上海市肿瘤研究所   上海市胆道疾病研究重点实验室,上海200127
  • 出版日期:2022-11-01 发布日期:2022-11-18

  • Online:2022-11-01 Published:2022-11-18

摘要: 胰腺癌恶性程度高,预后差,早期临床症状不典型,发现时已失去手术机会,故亟需一种精准的早期筛查手段。肿瘤标记物的相关研究近年来发展迅速,大量胰腺癌肿瘤标记物涌现,可分为糖脂和蛋白质类、黏附分子、非编码RNA和微生物等。同时,多种肿瘤标记物联合检测的研究也逐渐增多,大大提高了诊断敏感度和特异度。随着技术的进步,液体活检和光学分子成像等技术进一步拓宽肿瘤标记物的应用范畴,为精准医疗带来新契机。

关键词: 胰腺癌, 肿瘤标记物, 液体活检

Abstract: The research and application progress of tumor markers in pancreatic cancer        FENG Jia-yi, ZHAO Yu-hao, WANG Xu-an, et al. Department of Biliary and Pancreatic Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine; Shanghai Cancer Institute; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200127, China
Corresponding author: LIU Ying-bin, E-mail:laoniulyb@
shsmu.edu.cn
Abstract    Pancreatic Cancer (PC) is one of the most lethal malignancies featuring poor prognosis and atypical early clinical symptoms. Patients usually lose the opportunity for surgical resection when diagnosed. Therefore, accurate early screening methods for pancreatic cancer are in urgently needed. Studies in tumor markers have progressed rapidly in recent years, and a large number of pancreatic cancer tumor markers, which can be categorized as glycolipids, proteins, adhesion molecules, non-coding RNAs and microorganisms, etc., have been identified. At the same time, the number of research studies on the joint detection of multiple tumor markers has gradually increased, significantly improving diagnostic sensitivity and specificity. The advancement in technology has allowed neo-diagnostic methods, such as liquid biopsy and optical molecular imaging, to broaden the application of tumor markers further and bring new chances for precision medicine.

Key words: pancreatic cancer, tumor markers, liquid biopsy